As part of our continual efforts to provide a holistic look at the many therapeutic uses for psychedelic substances, Psychedelic Times regularly reaches out to psychedelic researchers, visionaries, and advocates. These interviews help us provide holistic, thorough information for our readers while honoring the experiences of individuals from all walks of life. We would like to sincerely thank every interviewee who has generously taken the time to share their knowledge and ideas with us. If you are interested in lending your voice to Psychedelic Times, please contact us for more information, and enjoy reading the perspectives of the some of the best people in the field of psychedelic research, therapy, integration, and recovery coaching.
Why Is the Cannabis Industry Struggling to Build Social Equity in the City of Angels? An Interview with Kristen Lovell of the Social Impact Center, Los Angeles
On Friday March 15, 2019 cannabis activists protested in Austin, Texas outside South by Southwest (SXSW) as former U.S. House Speaker John Boehner presented on the cannabis industry with Acreage Holdings C.E.O. Kevin Murphy. They also spoke out against MedMen CEO Adam...
“Our lawmakers don’t talk to their constituents.” An Interview with New Mexico Activist Monique Chavez on Why Pot Legalization Failed In Her State
On March 16, 2019, the New Mexico state legislature took important steps towards improving access to cannabis. They included separate measures to decriminalize personal possession of cannabis, expand the existing medical marijuana program, and increase the rights of...
FDA Approves Ketamine-Derived Treatment for Depression, But How Are People Really Using It? A Conversation with Kellye Greene of New York DanceSafe
On March 5, 2019, the FDA approved Spravato (esketamine), an intranasal spray for treatment-resistant depression. The drug is chemically very similar to generic ketamine, which is used around the world as a reliable anaesthetic in both human and veterinary surgery. It...
